Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Enfermedad de Alzheimer y Demencias

517 ARTÍCULOS , VIENDO DEL 286 AL 300

Paving the Way for Alzheimer's Disease Prevention: A Systematic Review of Global Open-Access Neuroimaging Datasets in Healthy Individuals

Ly M, Yu GZ, Chwa WJ, Raji CA.

J Alzheimers Dis. 2023;96(4):1441-1451. doi: 10.3233/JAD-230738.

Functional connectivity changes in mild cognitive impairment: A meta-analysis of M/EEG studies

Buzi G, Fornari C, Perinelli A, Mazza V.

Clin Neurophysiol. 2023 Dec;156:183-195. doi: 10.1016/j.clinph.2023.10.011. Epub 2023 Nov 2.

Cerebrovascular Hemodynamics in Cognitive Impairment and Dementia: A Systematic Review and Meta-Analysis of Transcranial Doppler Studies

Fresnais D, Ihle-Hansen H, Lundström E, Andersson ÅG, Fure B.

Dement Geriatr Cogn Disord. 2023;52(5-6):277-295. doi: 10.1159/000535422. Epub 2023 Nov 26.

How healthy participants value additional diagnostic testing with amyloid-PET in patients diagnosed with mild cognitive impairment - a bidding game experiment

van Maurik IS, Bakker ED, van Unnik AAJM, Broulikova HM, Zwan MD, van de Giessen E, Berkhof J, Bouwman FH, Bosmans JE, van der Flier WM.

Alzheimers Res Ther. 2023 Nov 28;15(1):208. doi: 10.1186/s13195-023-01346-y.

[Expert consensus on the application of amyloid-PET imaging in the diagnosis of Alzheimer's disease]

Chinese Society of Dementia and Cognitive lmpairment; Chinese Society of Nuclear Medicine.

Zhonghua Yi Xue Za Zhi. 2023 Dec 5;103(45):3615-3626. doi: 10.3760/cma.j.cn112137-20230909-00433.

Efficacy of the visual cognitive assessment test for mild cognitive impairment/mild dementia diagnosis: a meta-analysis

Hsu JH, Liu CC, Chen IW, Wu JY, Huang PY, Liu TH, Hung KC.

Front Public Health. 2023 Oct 31;11:1293710. doi: 10.3389/fpubh.2023.1293710. eCollection 2023.

Reducing fear and avoidance of memory loss improves mood and social engagement in community-based older adults: a randomized trial

Farina FR, Regan J, Marquez M, An H, O'Loughlin P, Pavithra P, Taddeo M, Knight RC, Bennett M, Lenaert B, Griffith JW.

BMC Geriatr. 2023 Nov 29;23(1):786. doi: 10.1186/s12877-023-04470-4.

The association between bullous pemphigoid and cognitive outcomes in middle-aged and older adults: A systematic review and meta-analysis

Zhou Q, Xiong Z, Yang D, Xiong C, Li X.

PLoS One. 2023 Nov 30;18(11):e0295135. doi: 10.1371/journal.pone.0295135. eCollection 2023.

Increased risk of osteoporosis in patients with cognitive impairment: a systematic review and meta-analysis

Xie C, Wang C, Luo H.

BMC Geriatr. 2023 Dec 4;23(1):797. doi: 10.1186/s12877-023-04548-z.

NeuroEPO plus (NeuralCIM(®)) in mild-to-moderate Alzheimer's clinical syndrome: the ATHENEA randomized clinical trial

Sosa S, Bringas G, Urrutia N, Peñalver AI, López D, González E, Fernández A, Hernández ZM, Viña A, Peña Y, Batista JF, Valenzuela C, León K, Crombet T, Rodríguez T, Pérez L; ATHENEA Investigators.

Alzheimers Res Ther. 2023 Dec 13;15(1):215. doi: 10.1186/s13195-023-01356-w.

Circular RNAs in Alzheimer's Disease: A New Perspective of Diagnostic and Therapeutic Targets

Vakili O, Asili P, Babaei Z, Mirahmad M, Keshavarzmotamed A, Asemi Z, Mafi A.

CNS Neurol Disord Drug Targets. 2023;22(9):1335-1354. doi: 10.2174/1871527321666220829164211.

Phospho-tau with subthreshold tau-PET predicts increased tau accumulation rates in amyloid-positive individuals

Groot C, Smith R, Stomrud E, Binette AP, Leuzy A, Wuestefeld A, Wisse LEM, Palmqvist S, Mattsson-Carlgren N, Janelidze S, Strandberg O, Ossenkoppele R, Hansson O.

Brain. 2023 Apr 19;146(4):1580-1591. doi: 10.1093/brain/awac329.

Ocular Biomarkers for Alzheimer Disease Dementia: An Umbrella Review of Systematic Reviews and Meta-analyses

Costanzo E, Lengyel I, Parravano M, Biagini I, Veldsman M, Badhwar A, Betts M, Cherubini A, Llewellyn DJ, Lourida I, MacGillivray T, Rittman T, Tamburin S, Tai XY, Virgili G.

JAMA Ophthalmol. 2023 Jan 1;141(1):84-91. doi: 10.1001/jamaophthalmol.2022.4845.

Plasma biomarkers for neurodegenerative disorders: ready for prime time?

Balogun WG, Zetterberg H, Blennow K, Karikari TK.

Curr Opin Psychiatry. 2023 Mar 1;36(2):112-118. doi: 10.1097/YCO.0000000000000851. Epub 2023 Jan 16.

Shaping the risk for late-life neurodegenerative disease: A systematic review on prenatal risk factors for Alzheimer's disease-related volumetric brain biomarkers

Boots A, Wiegersma AM, Vali Y, van den Hof M, Langendam MW, Limpens J, Backhouse EV, Shenkin SD, Wardlaw JM, Roseboom TJ, de Rooij SR.

Neurosci Biobehav Rev. 2023 Mar;146:105019. doi: 10.1016/j.neubiorev.2022.105019. Epub 2023 Jan 3.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias